GLP-1 drugs like Ozempic, Mounjaro, Zepbound and Wegovy are being explored for treating an array of conditions including sleep apnea, kidney disease, addiction, Parkinson’s and Alzheimer’s. Read this story
GLP-1 drugs like Ozempic, Mounjaro, Zepbound and Wegovy are being explored for treating an array of conditions including sleep apnea, kidney disease, addiction, Parkinson’s and Alzheimer’s. Read this story
More from Forbes | ozempic glp-1 mounjaro weight loss sleep apnea FDA label mental health parkinson's alzheimer's Eli Lilly and Company Anti-obesity medication Weight loss Obstructive sleep apnea Obesity